Clinical
New clinical trial registered for Lanreotide
Related compound: LanreotideView source →
Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study (NCT07534371) registered on ClinicalTrials.gov. Phase: Not specified. Status: active not recruiting.